Vaginal cuff brachytherapy practice in endometrial cancer patients: a report from the Turkish Oncology Group

被引:1
|
作者
Bolukbasi, Yasemin [1 ,2 ]
Onal, Cem [3 ]
Ozsaran, Zeynep [4 ]
Senyurek, Sukran [1 ]
Akdemir, Eyub Yasar [1 ]
Selek, Ugur [1 ]
Yildiz, Ferah [5 ]
机构
[1] Koc Univ, Fac Med, Dept Radiat Oncol, Davutpasa Caddesi 4, TR-34010 Istanbul, Turkey
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Baskent Univ, Fac Med, Dept Radiat Oncol, Adana Dr Turgut Noyan Res & Treatment Ctr, Adana, Turkey
[4] Ege Univ, Fac Med, Dept Radiat Oncol, Izmir, Turkey
[5] Hacettepe Univ Ankara, Fac Med, Dept Radiat Oncol, Ankara, Turkey
关键词
brachytherapy; vaginal cuff; experience; survey; DOSE-RATE BRACHYTHERAPY; AMERICAN BRACHYTHERAPY; PRACTICE PATTERNS; RISK; RADIOTHERAPY; ORGANS; DOSIMETRY; CARCINOMA; STENOSIS; TRENDS;
D O I
10.5114/jcb.2021.105282
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The American Brachytherapy Association is attempting to develop standards for delivering brachytherapy, although differences in practice have been reported in the literature. This study evaluated vaginal cuff brachytherapy (VBT) practice and quality of life-related recommendations among Turkish radiation oncologists. Material and methods: A nationwide web-based 17-item survey was distributed to the members of the Turkish Society for Radiation Oncology. These members received e-mail notifications, and a link was posted on the Turkish Society for Radiation Oncology internet site to solicit voluntary responses The survey addressed the simulation processes, target volume, prescribed dose, delivery schedules, and recommendations related to vaginal side effects. Results: Fifty-seven radiation oncologists responded to the survey. The most used dose fraction schemes for adjuvant VBT were 7 Gy x 3 fractions (30%), 5.5 Gy x 5 fractions (26%), and 6 Gy x 5 fractions (28%). The preferred VBT scheme was 5 Gy x 3 fractions (50%) when the external beam radiotherapy (EBRT) dose was 45 Gy external radiotherapy, while the preferred schemes were 6 Gy x 3 fractions (30%) or 5 Gy x 3 fractions (32%) when the external radiotherapy dose was increased to 50.4 Gy. One-half of the respondents delivered VBT twice a week, and the dose was prescribed to 0.5 cm from vaginal mucosa by 86% of the respondents. There was no common definition for the dose prescription length, which was defined as 3 cm from the vaginal cuff in 33% of responses and as 4 cm in 35% of responses. For serous and clear cell histological types, 38% of the respondents targeted "full cylinder length". To prevent vaginal side effects, 78% of the respondents recommended using a vaginal dilator and/or sexual intercourse after VBT. Conclusions: This survey revealed variations in the clinical practice of VBT among Turkish radiation oncologists, which suggests that standardization is necessary.
引用
收藏
页码:152 / 157
页数:6
相关论文
共 50 条
  • [21] Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation
    Parsons, Matthew W.
    Huang, Y. Jessica
    Burt, Lindsay
    Suneja, Gita
    Gaffney, David
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (03) : 311 - 315
  • [22] Direct health care cost to provide adjuvant vaginal cuff brachytherapy for endometrial cancer
    Dutta, S. W.
    Wu, T. C.
    Libby, B.
    Lash, D. J.
    Romano, K. D.
    Showalter, T. N.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 182 - 182
  • [23] American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review
    Harkenrider, Matthew M.
    Block, Alec M.
    Alektiar, Kaled M.
    Gaffney, David K.
    Jones, Ellen
    Klopp, Ann
    Viswanathan, Akila N.
    Small, William, Jr.
    BRACHYTHERAPY, 2017, 16 (01) : 95 - 108
  • [24] Clinical outcome and toxicity of MRI-based vaginal cuff brachytherapy in endometrial cancer
    Jaisawang, C.
    Alisanant, P.
    Shotelersuk, K.
    Khorprasert, C.
    Amornwichet, N.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S807 - S808
  • [25] Adjuvant high dose rate vaginal cuff brachytherapy for early stage endometrial cancer
    Tannehill, SP
    Petereit, DG
    Schink, JC
    Grosen, EA
    Hartenbach, EM
    Thomadsen, BR
    Buchler, DA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 296 - 296
  • [26] Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
    Eldredge-Hindy, Harriet Belding
    Eastwick, Gary
    Anne, Pramila Rani
    Rosenblum, Norman G.
    Schilder, Russell J.
    Chalian, Raffi
    Zibelli, Allison M.
    Kim, Christine H.
    Den, Robert
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2014, 6 (03) : 262 - 270
  • [27] Vaginal cuff HDR brachytherapy alone is sufficient adjuvant treatment for patients with surgical stage I endometrial cancer
    Solhjem, MC
    Petersen, IA
    Haddock, MG
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S213 - S214
  • [28] Postoperative vaginal brachytherapy in endometrial cancer
    Mazeron, Renaud
    Khodari, Wassim
    Gilmore, Jennifer
    Champoudry, Jerome
    Dumas, Isabelle
    Morice, Philippe
    Lhomme, Catherine
    Haie-Meder, Christine
    BULLETIN DU CANCER, 2012, 99 (01) : 69 - 77
  • [29] Understanding Anxiety in Patients Receiving Vaginal Brachytherapy for Endometrial Cancer
    Park, D.
    Sawin, Y.
    Niemierko, A.
    Foote, C.
    Irwin, K.
    Russo, A. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E273 - E273
  • [30] VAGINAL LENGTH AFTER VAGINAL BRACHYTHERAPY FOR ENDOMETRIAL CANCER
    Small, W.
    Lin, L.
    Strauss, J.
    Xiao, C.
    Bruner, D. W.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 198 - 198